BC
OGN icon

Bayforest Capital’s Organon & Co OGN Stock Holding History

Bayforest Capital’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.8K Sell
869
-23,880
-96% -$286K 0.01% 830
2026
Q1 		$148K Sell
24,749
-20,278
-45% -$153K 0.17% 218
2025
Q4 		$323K Sell
45,027
-16,102
-26% -$127K 0.24% 111
2025
Q3 		$653K Buy
61,129
+60,070
+5,672% +$590K 0.31% 75
2025
Q2 		$10.3K Buy
+1,059
New +$10.9K ﹤0.01% 630

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Bayforest Capital's OGN Position: Q2 2026 in Review

Bayforest Capital reduced its Organon & Co (OGN) stake by 96% in Q2 2026, selling an estimated $286K and leaving 869 shares worth $11.8K. The position accounts for 0.01% of the portfolio, ranked #830.

Bayforest Capital first reported a position in OGN in Q2 2025 and has held it in 5 quarters since. The position peaked at $653K in Q3 2025. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Bayforest Capital held 869 shares of Organon & Co worth $11.8K as of Q2 2026.
  • Bayforest Capital sold 23,880 Organon & Co shares in Q2 2026, an estimated $286K.
  • Organon & Co made up 0.01% of Bayforest Capital's portfolio in Q2 2026, its #830 holding.
  • Bayforest Capital first reported a position in Organon & Co in Q2 2025 and has held it in 5 quarters since.
  • Bayforest Capital's Organon & Co position peaked at $653K in Q3 2025.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Bayforest Capital's 13F filing for Q2 2026, filed 5 Aug 2026.